Vera Therapeutics (NASDAQ: VERA) Just Broke Out on a Major FDA Approval — Could Soar 22%–35%
Plus, our recommended trade with VKTX touched our first price target to deliver a potential 19% return from entry in just under two weeks.
Read MorePosted by Tara Young and Greg Patrick, Trades Of The Day | Jul 8, 2026
Plus, our recommended trade with VKTX touched our first price target to deliver a potential 19% return from entry in just under two weeks.
Read MorePosted by Tara Young and Greg Patrick, Trades Of The Day | Jul 7, 2026
Plus, our recommended trade with CLBT touched our first price target to deliver a potential 20% return from entry.
Read MorePosted by Tara Young and Greg Patrick, Trades Of The Day | Jul 6, 2026
Plus, our recommended trade with ABBV touched our first price target to deliver a potential 12% return from entry in under two weeks.
Read MorePosted by Tara Young and Greg Patrick, Trades Of The Day | Jul 5, 2026
This week’s list runs small and speculative — six names under $25 and four in healthcare, three of them biotech.
Read MorePosted by Tara Young and Greg Patrick, Trades Of The Day | Jul 2, 2026
Plus, two stocks from our Top 10 Breakout Watchlist this week have already cleared our recommended buy levels.
Read More
